Multiple sclerosis, lung cancer, and 50 marathons: Aaron Hawkins about to reach amazing milestone

“He has been a blessing and role model for so many,” his doctor Jonathan Nesbitt says.

Molecular testing across tumor types

The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

AI used to identify patients at risk for lung cancer

Pierre Massion

We are making progress

Philanthropist honored